Article

Scale-up Production and Immunological Assessment of Recombinant SARS- CoV-2 Spike RBD in Pichia pastoris

2022-11-09

Abstract excerpt

With more than two years in COVID-19 pandemic, the underlying virus is mutating which indicates it is not over yet hence SARS-CoV-2 Spike RBD is a potent candidate for immunological development purposes. Here, we produced a recombinant-RBD protein from micro- to macro-scale production by Pichia pastoris with high purity that was assessed by immunological tests. A recombinant-RBD compromising 283 residues (31kDa) w...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f848b453-4c6e-582d-8bbf-129efd207c53
DOI: 10.21203/rs.3.rs-2242046/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Scale-up Production and Immunological Assessment of Recombinant SARS- CoV-2 Spike RBD in Pichia pastorisDOI 10.21203/rs.3.rs-2242046/v1Read

Yeast-expressed Recombinant SARS-CoV-2 Receptor Binding Domain, RBD203-N1 as a COVID-19 Protein Vaccine CandidateSemantic proximity Read

Scalable Production of a <i>De Novo</i> SARS-CoV-2 Antiviral miniprotein in E <i>scherichia coli</i>Semantic proximity Read

A Vaccine Based on the Receptor-Binding Domain of the Spike Protein Expressed in Glycoengineered Pichia pastoris Targeting SARS-CoV-2 Stimulates Neutralizing and Protective Antibody ResponsesSemantic proximity Read

Structural and functional comparison of SARS-CoV-2-spike receptor binding domain produced in Pichia pastoris and mammalian cellsSemantic proximity Read

Scalable, methanol-free manufacturing of the SARS-CoV-2 receptor binding domain in engineered <i>Komagataella phaffii</i>Semantic proximity Read

Yeast-produced RBD-based recombinant protein vaccines elicit broadly neutralizing antibodies and durable protective immunity against SARS-CoV-2 infectionSemantic proximity Read

Development and evaluation of a low cost IgG ELISA test based in RBD protein for COVID-19Semantic proximity Read

Identification of three conserved linear B cell epitopes on the SARS-CoV-2 spike proteinSemantic proximity Read

A study protocol to prepare an RBD protein for vaccine against COVID-19Semantic proximity Read

Designed SARS‐CoV‐2 receptor binding domain variants form stable monomersSemantic proximity Read

Purification and characterization of the receptor‐binding domain of SARS‐CoV‐2 spike protein from Escherichia coliSemantic proximity Read

Enhancing the Immunogenicity of RBD Protein Variants through Amino Acid E484 Mutation in SARS-CoV-2.Semantic proximity Read